Bank Of America Corp Precigen, Inc. Transaction History

Bank Of America Corp

$1.06 Trillion
Q1 2024

A detailed history of Bank Of America Corp transactions in Precigen, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 132,190 shares of PGEN stock, worth $185,066. This represents 0.0% of its overall portfolio holdings.

Number of Shares

132,190

Previous 359,210 63.2%

Holding current value

$185,066

Previous $481,000 60.29%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$1.21 - $1.75 $274,694 - $397,285	-227,020 Reduced 63.2%	132,190 $191,000
Q4 2023 Feb 14, 2024	BUY	$0.89 - $1.41 $148,342 - $235,014	166,677 Added 86.57%	359,210 $481,000
Q2 2023 Aug 14, 2023	SELL	$0.96 - $1.4 $1.07 Million - $1.57 Million	-1,117,878 Reduced 85.31%	192,533 $221,000
Q1 2023 May 12, 2023	BUY	$0.88 - $2.19 $1.05 Million - $2.62 Million	1,198,195 Added 1067.76%	1,310,411 $1.39 Million
Q4 2022 Feb 10, 2023	BUY	$1.27 - $2.26 $21,910 - $38,989	17,252 Added 18.17%	112,216 $170,000

Q3 2022 Nov 14, 2022	BUY	$1.41 - $2.79 $57,420 - $113,619	40,724 Added 75.08%	94,964 $201,000
Q2 2022 Aug 12, 2022	BUY	$1.15 - $2.53 $13,993 - $30,785	12,168 Added 28.92%	54,240 $72,000
Q1 2022 May 16, 2022	SELL	$1.91 - $3.98 $366,949 - $764,637	-192,120 Reduced 82.04%	42,072 $89,000
Q4 2021 Feb 08, 2022	BUY	$3.53 - $5.5 $607,685 - $946,819	172,149 Added 277.47%	234,192 $868,000
Q3 2021 Nov 15, 2021	BUY	$4.99 - $6.55 $29,760 - $39,064	5,964 Added 10.63%	62,043 $309,000
Q2 2021 Sep 13, 2021	BUY	$6.24 - $8.22 $349,932 - $460,969	56,079 New	56,079 $365,000

Others Institutions Holding PGEN

# of Institutions

141

Shares Held

145M

Call Options Held

208K

Put Options Held

43.7K

View Full List

About PRECIGEN, INC.

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $291M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

More about PGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Precigen, Inc. Transaction History